世界の静脈注射用鉄剤市場は2022年に約29億2,000万米ドルと評価され、2023年から2030年の予測期間にわたって8.6％を超える健全な成長率で成長すると予想されています。静脈注射用鉄剤は、体内の鉄貯蔵量を補充するために血流に直接投与される薬剤です。経口鉄サプリメントが効果がない場合、または不適切な場合に使用されます。これらの薬は、体内の鉄レベルを急速に上昇させることにより、鉄欠乏性貧血の治療に役立ちます。静脈内鉄剤使用の重要な適応症である慢性腎臓病、炎症性腸疾患、がんの有病率の上昇は、市場成長の重要な原動力となっています。さらに、マラリア、HIV/AIDS、結核、肝炎、肺炎、インフルエンザなどの感染症の発生率の増加により、将来的には静脈内薬の需要が増加すると予想されています。
さらに、がんの有病率の増加は、静脈注射用鉄剤市場の成長をサポートする可能性があります。2022 年の WHO によると、2020 年の 1,000 万人近くの死亡原因はがんであり、依然として世界的な死亡の顕著な原因となっています。2020年の新規がん患者数に関しては、乳がんが226万人で最も多く、次いで肺がんが221万人、結腸がんと直腸がんが193万人、前立腺がんが141万人、 2020年には非黒色腫皮膚がんが120万件、胃がんが109万件となりました。さらに、医薬品開発への投資の増加により、予測期間中に市場に有利な機会が生まれると予想されます。ただし、静脈注射用鉄剤に関連する副作用は、2023年から2030年の予測期間を通じて市場の成長を阻害します。
世界の静脈注射用鉄剤市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカが含まれます。北アメリカは、この地域で慢性腎臓病、胃腸疾患、がんの有病率が増加しているため、2022年に市場を独占しました。アジア太平洋地域は、政府の支援的な取り組みと医療インフラの発展により、予測期間中に最も高い成長率で成長すると予想されています。さらに、中国やインドなどの発展途上国では慢性腎臓病の発生率が高いことが市場の成長を助けています。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Intravenous Iron Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Intravenous Iron Drugs Market, by Product, 2020-2030 (USD Billion)
1.2.3. Intravenous Iron Drugs Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Intravenous Iron Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Intravenous Iron Drugs Market Dynamics
3.1. Intravenous Iron Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising Incidences of Chronic Kidney Disease
3.1.1.2. Growing incidence of infectious diseases
3.1.2. Market Challenges
3.1.2.1. Adverse reactions associated with intravenous iron drugs
3.1.3. Market Opportunities
3.1.3.1. Growing investment in drugs development
Chapter 4. Global Intravenous Iron Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Intravenous Iron Drugs Market, by Product
5.1. Market Snapshot
5.2. Global Intravenous Iron Drugs Market by Product, Performance - Potential Analysis
5.3. Global Intravenous Iron Drugs Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Intravenous Iron Drugs Market, Sub Segment Analysis
5.4.1. Iron Sucrose
5.4.2. Iron Dextran
5.4.3. Ferric Carboxymaltose
5.4.4. Others
Chapter 6. Global Intravenous Iron Drugs Market, by Application
6.1. Market Snapshot
6.2. Global Intravenous Iron Drugs Market by Application, Performance - Potential Analysis
6.3. Global Intravenous Iron Drugs Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Intravenous Iron Drugs Market, Sub Segment Analysis
6.4.1. Chronic Kidney Disease
6.4.2. Inflammatory Bowel Disease
6.4.3. Cancer
6.4.4. Others
Chapter 7. Global Intravenous Iron Drugs Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Intravenous Iron Drugs Market, Regional Market Snapshot
7.4. North America Intravenous Iron Drugs Market
7.4.1. U.S. Intravenous Iron Drugs Market
7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Intravenous Iron Drugs Market
7.5. Europe Intravenous Iron Drugs Market Snapshot
7.5.1. U.K. Intravenous Iron Drugs Market
7.5.2. Germany Intravenous Iron Drugs Market
7.5.3. France Intravenous Iron Drugs Market
7.5.4. Spain Intravenous Iron Drugs Market
7.5.5. Italy Intravenous Iron Drugs Market
7.5.6. Rest of Europe Intravenous Iron Drugs Market
7.6. Asia-Pacific Intravenous Iron Drugs Market Snapshot
7.6.1. China Intravenous Iron Drugs Market
7.6.2. India Intravenous Iron Drugs Market
7.6.3. Japan Intravenous Iron Drugs Market
7.6.4. Australia Intravenous Iron Drugs Market
7.6.5. South Korea Intravenous Iron Drugs Market
7.6.6. Rest of Asia Pacific Intravenous Iron Drugs Market
7.7. Latin America Intravenous Iron Drugs Market Snapshot
7.7.1. Brazil Intravenous Iron Drugs Market
7.7.2. Mexico Intravenous Iron Drugs Market
7.8. Middle East & Africa Intravenous Iron Drugs Market
7.8.1. Saudi Arabia Intravenous Iron Drugs Market
7.8.2. South Africa Intravenous Iron Drugs Market
7.8.3. Rest of Middle East & Africa Intravenous Iron Drugs Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. CSL Limited
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Covis Pharma GmbH
8.3.3. Daiichi Sankyo Company, Ltd.
8.3.4. Sanofi S.A.
8.3.5. Pharma cosmos A/S
8.3.6. Shield Therapeutics Plc
8.3.7. AbbVie Inc.
8.3.8. Rockwell Medical Inc
8.3.9. Americal Reagent Inc
8.3.10. Pfizer Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
List of Tables
TABLE 1. Global Intravenous Iron Drugs Market, report scope
TABLE 2. Global Intravenous Iron Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Intravenous Iron Drugs Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Intravenous Iron Drugs Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Intravenous Iron Drugs Market
TABLE 70. List of primary sources, used in the study of global Intravenous Iron Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Intravenous Iron Drugs Market, research methodology
FIG 2. Global Intravenous Iron Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Intravenous Iron Drugs Market, key trends 2022
FIG 5. Global Intravenous Iron Drugs Market, growth prospects 2023-2030
FIG 6. Global Intravenous Iron Drugs Market, porters 5 force model
FIG 7. Global Intravenous Iron Drugs Market, pest analysis
FIG 8. Global Intravenous Iron Drugs Market, value chain analysis
FIG 9. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Intravenous Iron Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
